tiprankstipranks
Trending News
More News >
Razor Labs Ltd. (IL:RZR)
:RZR
Israel Market
Advertisement

Razor Labs (RZR) AI Stock Analysis

Compare
0 Followers

Top Page

IL:RZR

Razor Labs

(RZR)

Rating:45Neutral
Price Target:
433.00
▼(-2.48% Downside)
Razor Labs' overall stock score is primarily impacted by its challenging financial performance, characterized by declining revenues and persistent losses. The technical analysis indicates a bearish trend, and the valuation is unattractive due to a negative P/E ratio and no dividend yield. These factors collectively contribute to a low stock score.
Positive Factors
Business Model Strength
The company's focus on AI and SaaS models provides a scalable revenue stream, leveraging recurring fees and strategic partnerships, which can drive long-term growth.
Leverage Management
Improved leverage management indicates better financial discipline, potentially enhancing financial stability and reducing risk over time.
Industry Focus
Focusing on AI for industrial sectors positions the company to capitalize on growing demand for efficiency and productivity solutions, supporting long-term market relevance.
Negative Factors
Revenue Decline
Declining revenue trends signal challenges in market penetration and customer retention, potentially impacting future growth and profitability.
Profitability Challenges
Persistent negative margins indicate operational inefficiencies and challenges in achieving profitability, which could hinder long-term financial health.
Cash Flow Volatility
Volatile cash flows suggest difficulties in sustaining operations and funding growth initiatives, posing risks to liquidity and financial stability.

Razor Labs (RZR) vs. iShares MSCI Israel ETF (EIS)

Razor Labs Business Overview & Revenue Model

Company DescriptionRazor Labs operates in the artificial intelligence (AI) industry in Israel. It offers DataMind, an industrial optimization platform to take manufacturing process into a virtual world; and AI pipeline, a video analytics platform to chain together various AI applications into one solution that fit corporate objectives. The company is based in Tel Aviv, Israel.
How the Company Makes MoneyRazor Labs generates revenue primarily through the sale and subscription of its AI-driven solutions and platforms to industrial clients. The company offers software-as-a-service (SaaS) models where clients pay recurring fees to access and utilize their AI tools. Additionally, Razor Labs engages in custom AI solution development for specific industrial needs, which can involve one-time project fees or long-term service contracts. Key revenue streams also include strategic partnerships with industry players, which may involve revenue sharing or joint ventures to co-develop AI technologies tailored to specific industrial applications.

Razor Labs Financial Statement Overview

Summary
Razor Labs faces significant financial challenges with declining revenues, persistent losses, and inconsistent cash flows. Despite slight improvements in leverage, the company's profitability and cash generation capabilities remain concerning.
Income Statement
40
Negative
Razor Labs has shown a volatile revenue trend with a significant decline in recent years. The gross profit margin is weak, and the company is experiencing negative net and EBIT margins, indicating substantial operational challenges. The company has been unable to maintain profitability, as evidenced by consecutive years of negative net income.
Balance Sheet
50
Neutral
The company's debt-to-equity ratio has improved slightly, indicating better leverage management. However, the return on equity remains negative due to persistent losses. The equity ratio has decreased over time, suggesting a declining asset base relative to equity. Overall, the balance sheet reflects mixed stability and potential liquidity concerns.
Cash Flow
45
Neutral
Razor Labs has faced difficulties in maintaining positive operating cash flow, and free cash flow has been inconsistent. The operating cash flow to net income ratio is volatile, reflecting inconsistent cash generation relative to reported losses. These challenges highlight potential liquidity issues and the need for improved cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue8.24M17.22M5.29M5.14M14.20M22.30M
Gross Profit2.15M7.14M648.00K1.60M1.91M11.23M
EBITDA-15.09M-10.81M-13.70M-23.32M-40.95M1.50M
Net Income-16.52M-15.48M-18.33M-27.56M-41.57M-7.00K
Balance Sheet
Total Assets73.26M79.93M82.82M71.30M101.22M23.48M
Cash, Cash Equivalents and Short-Term Investments48.47M55.29M58.63M44.52M71.12M2.04M
Total Debt15.82M18.28M20.68M23.23M22.71M11.90M
Total Liabilities54.62M68.77M57.23M28.49M31.34M18.86M
Stockholders Equity18.62M11.14M25.57M42.80M69.88M4.61M
Cash Flow
Free Cash Flow12.99M-567.00K17.11M-23.98M-36.43M1.27M
Operating Cash Flow13.05M-308.00K17.25M-23.84M-32.78M1.53M
Investing Cash Flow-3.91M6.96M-7.47M42.34M-45.22M812.00K
Financing Cash Flow-3.01M-2.83M-2.38M-3.17M105.08M-1.19M

Razor Labs Technical Analysis

Technical Analysis Sentiment
Negative
Last Price444.00
Price Trends
50DMA
465.54
Negative
100DMA
478.47
Negative
200DMA
488.70
Negative
Market Momentum
MACD
-4.93
Negative
RSI
44.22
Neutral
STOCH
63.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:RZR, the sentiment is Negative. The current price of 444 is below the 20-day moving average (MA) of 457.93, below the 50-day MA of 465.54, and below the 200-day MA of 488.70, indicating a bearish trend. The MACD of -4.93 indicates Negative momentum. The RSI at 44.22 is Neutral, neither overbought nor oversold. The STOCH value of 63.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:RZR.

Razor Labs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$36.58B11.16-10.43%1.86%8.71%-7.09%
45
Neutral
182.67M
238.35%-0.43%
106.37M11.59
119.13M141.58
84.09M29.69
110.11M75.92
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:RZR
Razor Labs
444.00
12.30
2.85%
IL:ORAD
Orad
113.40
54.90
93.85%
IL:SADE
Sade Real Estat
664.60
452.60
213.49%
IL:CLAB
C-Lab
992.50
31.00
3.22%
IL:UTRN
Utron
534.20
164.30
44.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 11, 2025